127 related articles for article (PubMed ID: 14739366)
1. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia.
Gitler AD; Kong Y; Choi JK; Zhu Y; Pear WS; Epstein JA
Pediatr Res; 2004 Apr; 55(4):581-4. PubMed ID: 14739366
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-specific expression of Cre recombinase in transgenic mice.
Li WL; Cheng X; Tan XH; Zhang JS; Sun YS; Chen L; Yang X
Yi Chuan Xue Bao; 2005 Sep; 32(9):909-15. PubMed ID: 16201233
[TBL] [Abstract][Full Text] [Related]
3. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
[TBL] [Abstract][Full Text] [Related]
4. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
Kim A; Morgan K; Hasz DE; Wiesner SM; Lauchle JO; Geurts JL; Diers MD; Le DT; Kogan SC; Parada LF; Shannon K; Largaespada DA
Blood; 2007 Feb; 109(4):1687-91. PubMed ID: 17090653
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
[TBL] [Abstract][Full Text] [Related]
6. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.
Shannon KM; O'Connell P; Martin GA; Paderanga D; Olson K; Dinndorf P; McCormick F
N Engl J Med; 1994 Mar; 330(9):597-601. PubMed ID: 8302341
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders.
Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM
Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868
[TBL] [Abstract][Full Text] [Related]
8. Inherited predispositions and hyperactive Ras in myeloid leukemogenesis.
Lauchle JO; Braun BS; Loh ML; Shannon K
Pediatr Blood Cancer; 2006 May; 46(5):579-85. PubMed ID: 16261595
[TBL] [Abstract][Full Text] [Related]
9. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.
Le DT; Kong N; Zhu Y; Lauchle JO; Aiyigari A; Braun BS; Wang E; Kogan SC; Le Beau MM; Parada L; Shannon KM
Blood; 2004 Jun; 103(11):4243-50. PubMed ID: 14982883
[TBL] [Abstract][Full Text] [Related]
10. Nf1 and Gmcsf interact in myeloid leukemogenesis.
Birnbaum RA; O'Marcaigh A; Wardak Z; Zhang YY; Dranoff G; Jacks T; Clapp DW; Shannon KM
Mol Cell; 2000 Jan; 5(1):189-95. PubMed ID: 10678181
[TBL] [Abstract][Full Text] [Related]
11. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
[TBL] [Abstract][Full Text] [Related]
12. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
[TBL] [Abstract][Full Text] [Related]
13. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.
Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO
Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506
[TBL] [Abstract][Full Text] [Related]
14. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.
Zhu Y; Romero MI; Ghosh P; Ye Z; Charnay P; Rushing EJ; Marth JD; Parada LF
Genes Dev; 2001 Apr; 15(7):859-76. PubMed ID: 11297510
[TBL] [Abstract][Full Text] [Related]
15. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
Jacks T; Shih TS; Schmitt EM; Bronson RT; Bernards A; Weinberg RA
Nat Genet; 1994 Jul; 7(3):353-61. PubMed ID: 7920653
[TBL] [Abstract][Full Text] [Related]
16. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia.
Largaespada DA; Brannan CI; Jenkins NA; Copeland NG
Nat Genet; 1996 Feb; 12(2):137-43. PubMed ID: 8563750
[TBL] [Abstract][Full Text] [Related]
17. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
18. Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.
Ingram DA; Wenning MJ; Shannon K; Clapp DW
Blood; 2003 Mar; 101(5):1984-6. PubMed ID: 12393498
[TBL] [Abstract][Full Text] [Related]
19. Nf1 has an essential role in endothelial cells.
Gitler AD; Zhu Y; Ismat FA; Lu MM; Yamauchi Y; Parada LF; Epstein JA
Nat Genet; 2003 Jan; 33(1):75-9. PubMed ID: 12469121
[TBL] [Abstract][Full Text] [Related]
20. Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.
Zhang Y; Taylor BR; Shannon K; Clapp DW
J Clin Invest; 2001 Sep; 108(5):709-15. PubMed ID: 11544276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
